Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promacta for TKI-associated thrombocytopenia in CML and MF
NCT01428635Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2012
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eltrombopag in Thrombocytopenia, sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2012; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01428635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428635.